Neurocognitive Performance in Public Officials
15 juin 2026 mis à jour par: Gamze Demircioğlu, Atlas University
A Comparison of Neurocognitive Performance in Armed and Unarmed Public Officials
Public employees are exposed to varying levels of cognitive, physical, and psychosocial demands depending on the nature of their duties. In particular, armed public employees work under conditions that require rapid responses to environmental stimuli, effective use of attentional processes, and accurate decision-making within a limited time. These occupational demands may influence reaction time, neurocognitive performance, quality of life, and activity-role balance. Therefore, the aim of this study was to compare the neurocognitive performance of armed and unarmed public employees.
A total of 82 public employees, including 41 armed and 41 unarmed participants, were included in the study. Reaction time performance was assessed using the Light Trainer system. Neurocognitive performance was evaluated using the Stroop Test and the Digit Span Test. Quality of life was assessed using the Short Form-36 Health Survey (SF-36), and activity-role balance was evaluated using the Activity Role Balance Questionnaire.
Aperçu de l'étude
Statut
Complété
Les conditions
Type d'étude
Observationnel
Inscription (Réel)
82
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
-
Istanbul, Turquie (Türkiye)
- AtLAs Universty
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
Oui
Méthode d'échantillonnage
Échantillon non probabiliste
Population étudiée
The study population consists of full-time public officials aged 25-35 years who have been actively employed in public service for at least three years.
Participants will be categorized into two groups according to their occupational firearm-carrying status: armed public officials and unarmed public officials.
La description
Inclusion Criteria:
- Aged between 25 and 35 years.
- Actively employed as a public official for at least 3 years.
- A score of 26 or higher on the Mini-Mental State Examination (MMSE).
- Currently employed full-time.
- Able to understand and speak Turkish.
- Willing to participate in the study and provide informed consent.
Exclusion Criteria:
- Presence of a diagnosed neurological or psychiatric disorder.
- History of traumatic brain injury or severe head trauma within the past 6 months.
- Presence of an orthopedic condition or injury that may affect upper or lower extremity function.
- Presence of visual, auditory, or other sensory impairments that may interfere with test performance.
- Current use of medications or history of substance use that may affect cognitive performance.
- Previous exposure to or administration of the neurocognitive tests used in this study.
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
|---|
|
Armed Public Officials
Public officials who are legally authorized to carry firearms as part of their occupational duties.
|
|
Unarmed Public Officials
Public officials who are not authorized to carry firearms as part of their occupational duties.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Muscle Reaction Time
Délai: Baseline (single assessment)
|
Light Trainer® system, which consists of a wireless lighting system with LED pods and a central controller.
The participants were seated with their hands on the table, 40 cm apart, palms down, and elbows at 90°.
The Light Trainer was positioned centrally 20 cm away from each hand.
When the pod was illuminated, the participants were instructed to turn off the light as quickly as possible by touching it.
Light activation was randomized to avoid predictability, requiring participants to respond based on light cues each time.
In the first task, the participants used their dominant hand to turn off the light as quickly as possible.
In the second task, they responded to a light signal by deactivating a predetermined light from two different colors using their dominant hand.
Scale Range: No minimum or maximum value in milliseconds (lower time is better).
Interpretation: Lower reaction times signify better outcomes, as they reflect faster muscle response to visual stimuli.
|
Baseline (single assessment)
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Digit Span Test Performance
Délai: Baseline (single assessment)
|
Assesses attention and working memory using the Digit Span Test.
Performance is determined by the maximum number of digits correctly recalled in forward and backward sequences, with higher scores indicating better cognitive performance.
|
Baseline (single assessment)
|
|
Stroop Test Performance
Délai: Baseline (single assessment)
|
Assesses selective attention, cognitive flexibility, inhibitory control, and processing speed using the Stroop Test.
Performance is determined by the time required to complete the task and the number of errors made during the assessment.
|
Baseline (single assessment)
|
|
Quality of Life (SF-36)
Délai: Baseline (single assessment)
|
Assesses health-related quality of life using the Short Form-36 Health Survey (SF-36).
The SF-36 consists of 36 items and generates scores ranging from 0 to 100 for each domain, with higher scores indicating better health-related quality of life and better perceived health status across physical and mental health domains.
|
Baseline (single assessment)
|
|
Activity-Role Balance Questionnaire
Délai: Baseline (single assessment)
|
Assesses the perceived balance between daily activities and life roles using the Activity-Role Balance Questionnaire (ARBQ).
Scores range from 1 to 5, with higher scores indicating a more satisfactory balance between occupational roles and daily activities.
|
Baseline (single assessment)
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
3 novembre 2025
Achèvement primaire (Réel)
1 avril 2026
Achèvement de l'étude (Réel)
11 juin 2026
Dates d'inscription aux études
Première soumission
11 juin 2026
Première soumission répondant aux critères de contrôle qualité
15 juin 2026
Première publication (Réel)
16 juin 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
16 juin 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
15 juin 2026
Dernière vérification
1 juin 2026
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- ID_M_003
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
NON
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .